Table 4 Known groups validity testing: Comparison of QLQ-BN20 Scores as a function of KPS and MMSE
From: Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
| Â | Â | KPS | Effect size | MMSE** | Effect size | ||
|---|---|---|---|---|---|---|---|
|  |  | >80 | ≤80 | <27 | ≥27 | ||
Baseline | N = 53, | N = 141, | N = 91 | N = 103 | |||
Follow-up | N = 41 | N = 153 | |||||
BFU (future uncertainty) | Baseline*‡ | 42.7 (22.2) | 33.5 (24.7) | 0.38 | 33.9 (24.4) | 27.2 (23.4) | 0.28 |
Follow-up * | 37.0 (15.1) | 25.6 (24.5) | 0.50 | - | - | - | |
BVD (visual disorder) | Baseline *‡ | 38.3 (30.1) | 27.0 (27.3) | 0.40 | 28.1 (29.4) | 21.8 (22.8) | 0.24 |
Follow-up * | 33.3 (27.8) | 23.7 (26.1) | 0.36 | - | - | Â | |
BMD (motor dysfunction) | Baseline*‡ | 68.2 (31.8) | 24.6 (26.3) | 1.56 | 33.7 (30.2) | 16.5 (22.5) | 0.65 |
Follow-up * | 63.9 (29.1) | 22.4 (27.0) | 1.5 | - | - | Â | |
BCD (communication deficit) | Baseline *‡ | 44.9 (31.9) | 20.3 (26.5) | 0.88 | 26.1 (28.3) | 14.1 (21.8) | 0.48 |
Follow-up* | 45.0 (33.4) | 17.0 (22.6) | 1.11 | - | - | Â | |
BHA (headaches) | Baseline *‡ | 50.0 (36.0) | 44.3 (32.2) | 0.17 | 47.8 (28.6) | 34.8 (34.4) | 0.41 |
Follow-up * | 63.3 (36.7) | 42.5 (35.1) | 0.59 | - | - | Â | |
BSE (seizures) | Baseline *‡ | 15.1 (22.9) | 11.0 (23.3) | 0.18 | 14.3 (25.5) | 5.7 (15.6) | 0.41 |
Follow-up * | 14.8 (24.2) | 8.5 (21.2) | 0.29 | - | - | Â | |
BDR (drowsiness) | Baseline *‡ | 57.6 (30.1) | 28.3 (31.2) | 0.95 | 34.7 (33.3) | 22.3 (25.0) | 0.42 |
Follow-up * | 66.7 (27.2) | 26.6 (30.5) | 1.34 | - | - | Â | |
BHL (hair loss) | Baseline*‡ | 33.3 (35.1) | 22.1 (32.2) | 0.34 | 23.4 (32.8) | 16.8 (33.5) | 0.20 |
Follow-up* | 63.3 (36.7) | 42.5 (35.1) | 0.59 | - | - | Â | |
BIS (itchy skin) | Baseline*‡ | 33.3 (35.1) | 13.2 (24.7) | 0.72 | 19.2 (30.4) | 9.2 (17.6) | 0.41 |
Follow-up* | 40.0 (37.8) | 16.5 (26.5) | 0.80 | - | - | Â | |
BBC (bladder control) | Baseline*‡ | 45.4 (37.3) | 12.8 (24.2) | 1.15 | 19.0 (27.3) | 9.2 (23.4) | 0.39 |
| Â | Follow-up* | 50.0 (42.3) | 12.9 (28.2) | 0.97 | - | - | Â |